Figure 5.
Immunohistochemistry showed no difference for phospho-Smad 2 between AdTGF-β1 and -β3 (A–B) but a stronger positivity for AdTGF-β1 exposed TGFβ RI in alveolar epithelial cells (D–E) at day 7 (C and F: control vector).
Immunohistochemistry showed no difference for phospho-Smad 2 between AdTGF-β1 and -β3 (A–B) but a stronger positivity for AdTGF-β1 exposed TGFβ RI in alveolar epithelial cells (D–E) at day 7 (C and F: control vector).